Abbott Laboratories
Global healthcare company delivering diagnostics, medical devices, nutrition, and pharmaceuticals across 160+ countries.
Abbott Laboratories – About Abbott (Official Site)Abbott Laboratories is a global healthcare company founded in 1888 and headquartered in Chicago, Illinois. It operates across four business segments: medical devices, nutritional products, diagnostic products, and established pharmaceuticals sold outside the United States. The company employs approximately 114,000 people worldwide and operates in over 160 countries, trading on the NYSE under the ticker symbol ABT.
Abbott's medical devices segment is its largest and fastest-growing, accounting for roughly 45% of revenue in 2024 and generating over $21 billion in annual revenues as of 2025. Key product areas include cardiovascular health monitoring, glucose monitoring systems for diabetes care, and neuromodulation devices for chronic pain and movement disorders. Nutritional products (22%), diagnostics (20%), and pharmaceuticals (13%) make up the remainder of its revenue mix.
In fiscal year 2025, Abbott reported annual revenue of $44.33 billion, up from $41.95 billion in 2024—a roughly 5.7% year-over-year increase. The company has been led by president, CEO, and chairman Robert B. Ford since March 2020. In 2013, Abbott split into two entities, with AbbVie taking on the research-based pharmaceuticals business while Abbott retained focus on medical products.
Abbott's stated mission centers on creating innovative health technologies to help people live healthier lives. Given its scale in medical devices, diagnostics, and digital health tools, Abbott is highly relevant to innovations in health monitoring, connected care platforms, and next-generation diagnostic solutions.